Geneva PE Announces Funding and Launch of NXXIM
Geneva PE’s funding of NXXIM will create a cutting-edge AI platform that unifies affected person knowledge and empowers clinicians to make sooner selections, with pilot deployments in 2026. Geneva PE LLC (Geneva PE), a number one medtech-focused funding agency, in the present day introduced that it has funded and formally launched NXXIM, a next-generation AI-powered…
